UroGen Pharma to Participate at Upcoming Investor Conferences
May 07 2024 - 8:00AM
Business Wire
– Citizens JMP Life Sciences Conference –
– H.C. Wainwright 2nd Annual BioConnect
Conference –
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated
to developing and commercializing innovative solutions that treat
urothelial and specialty cancers, today announced that it will
present at the following investor conferences in May:
Citizens JMP Life Sciences Conference – May 14, 2024
Fireside Chat: May 14, 2024 at 10:00am ET Location: New York, NY
Webcast Registration Link: Here
H.C. Wainwright BioConnect Conference – May 20, 2024
Fireside Chat: May 20, 2024 at 9:00am ET Location: New York, NY
Webcast Registration Link: Here
About UroGen Pharma Ltd.
UroGen is a biotech company dedicated to developing and
commercializing innovative solutions that treat urothelial and
specialty cancers because patients deserve better options. UroGen
has developed RTGel reverse-thermal hydrogel, a proprietary
sustained-release, hydrogel-based platform technology that has the
potential to improve the therapeutic profiles of existing drugs.
UroGen’s sustained release technology is designed to enable longer
exposure of the urinary tract tissue to medications, making local
therapy a potentially more effective treatment option. Our first
product to treat LG-UTUC and investigational treatment UGN-102
(mitomycin) for intravesical solution for patients with low-grade
non-muscle invasive bladder cancer are designed to ablate tumors by
non-surgical means. UroGen is headquartered in Princeton, NJ with
operations in Israel. To learn more, visit www.UroGen.com or follow
us on X (Twitter), @UroGenPharma.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507449972/en/
INVESTOR CONTACT:
Vincent Perrone Senior Director, Investor Relations
vincent.perrone@urogen.com 609-460-3588 ext. 1093
MEDIA CONTACT:
Cindy Romano Director, Corporate Communications
cindy.romano@urogen.com 609-460-3583 ext. 1083
UroGen Pharma (NASDAQ:URGN)
Historical Stock Chart
From Apr 2024 to May 2024
UroGen Pharma (NASDAQ:URGN)
Historical Stock Chart
From May 2023 to May 2024